CareCloud (NASDAQ:CCLD – Get Free Report) posted its earnings results on Thursday. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.01), Zacks reports. CareCloud had a net margin of 7.87% and a return on equity of 24.10%. The business had revenue of $31.27 million during the quarter, compared to analyst estimates of $30.51 million.
Here are the key takeaways from CareCloud’s conference call:
- CareCloud is reaffirming 2026 guidance with revenue of $128M–$132M, adjusted EBITDA of $29M–$31M and GAAP EPS of $0.20–$0.23, signaling management confidence in the year ahead.
- The company’s AI portfolio is commercializing: stratusAI Desk Agent is in full release and reportedly handling approximately 75% of inbound calls for early adopters, with cirrusAI Notes and AI prior-authorization/coding in the pipeline.
- CareCloud closed a new $50 million credit facility ( $40M term / $10M revolver ), established an ATM for optionality, and pre-funded the May 15 redemption of Series B preferred (≈$41.6M), aiming to remove the preferred overhang with no common dilution.
- Near-term GAAP results are pressured by the Medsphere integration and higher intangible amortization—Q1 GAAP net income fell to about $0.9M and free cash flow declined to $2.4M, though adjusted EBITDA and adjusted EPS were roughly flat year-over-year.
- Management expects margin improvement as Medsphere platforms are modernized to cloud, AI is deployed internally and across products, and cross-sell into hospital customers ramps—these benefits are forward-looking and dependent on successful integration.
CareCloud Price Performance
Shares of NASDAQ CCLD traded down $0.11 during mid-day trading on Friday, reaching $2.36. The company had a trading volume of 1,868,985 shares, compared to its average volume of 640,554. The company has a current ratio of 1.05, a quick ratio of 1.03 and a debt-to-equity ratio of 0.01. The stock has a market cap of $100.28 million, a PE ratio of 21.46 and a beta of 1.60. The company has a 50-day moving average price of $3.08 and a two-hundred day moving average price of $2.99. CareCloud has a 1-year low of $1.84 and a 1-year high of $4.01.
Institutional Trading of CareCloud
Wall Street Analyst Weigh In
Several brokerages have commented on CCLD. Weiss Ratings reiterated a “hold (c-)” rating on shares of CareCloud in a research report on Friday, March 27th. Wall Street Zen cut shares of CareCloud from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 25th. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $3.25.
Check Out Our Latest Stock Analysis on CCLD
CareCloud Company Profile
CareCloud, Inc is a healthcare technology company that provides cloud-based practice management, electronic health record (EHR) and revenue cycle management (RCM) solutions to medical practices and health systems. Its flagship offering, the CareCloud Central platform, combines clinical, financial and administrative workflows into a single, unified system. The platform includes modules for scheduling, billing, coding, patient engagement and telehealth, enabling practices to streamline front- and back-office operations and improve overall practice performance.
Founded in 2009 and headquartered in Miami Beach, Florida, CareCloud serves small to mid-size physician groups and specialty clinics across the United States.
Read More
- Five stocks we like better than CareCloud
- Buffett Spent 60 Years Ignoring Tech and the Bill Is Coming Due
- Excited About Gold But Unsure of Its Trajectory? Try These 3 Approaches
- Dollar at a 3-Year Low: 3 Exporters Quietly Printing Money
- Water Infrastructure: Why This Boring Sector Could Get Exciting
Receive News & Ratings for CareCloud Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareCloud and related companies with MarketBeat.com's FREE daily email newsletter.
